Table 1.
miRNA | TF (p-value) |
---|---|
hsa-let-7a | E2F1 (7.65E-06), SP1 (6.05E-04) |
hsa-let-7i | E2F1 (4.33E-06), SP1 (4.64E-04) |
hsa-miR-106a | CTCF (2.04E-04), E2F1 (8.56E-07), SPI1 (1.59E-05), SP1 (1.24E-11), YY1 (1.47E-07) |
hsa-miR-106b | E2F1 (2.79E-07), SP1 (3.26E-08), YY1 (1.92E-06) |
hsa-miR-144 | E2F1 (3.67E-09), SPI1 (5.32E-09), SP1 (8.03E-08), YY1 (9.55E-12) |
hsa-miR-15a | E2F1 (5.61E-06), SP1 (2.12E-04), YY1 (1.24E-03) |
hsa-miR-15b | E2F1 (5.61E-06), SP1 (2.12E-04), YY1 (1.24E-03) |
hsa-miR-16 | E2F1 (1.25E-05), SP1 (1.66E-04), YY1 (7.63E-04) |
hsa-miR-17 | E2F1 (1.26E-04), SP1 (1.62E-05), YY1 (6.48E-06) |
hsa-miR-195 | E2F1 (1.25E-05), SP1 (1.66E-04), YY1 (7.63E-04) |
hsa-miR-19a | E2F1 (1.55E-04), SPI1 (6.00E-04), SP1 (2.99E-05), YY1 (6.16E-06) |
hsa-miR-19b | SP1 (1.55E-03), YY1 (2.03E-04) |
hsa-miR-20a | E2F1 (5.24E-07), SPI1 (6.91E-04), SP1 (9.00E-06), YY1 (3.06E-05) |
hsa-miR-20b | E2F1 (5.38E-04), SP1 (8.66E-08), YY1 (5.12E-05) |
hsa-miR-223 | YY1 (1.77E-03) |
hsa-miR-23a | E2F1 (3.24E-07), SPI1 (5.17E-04), SP1 (2.83E-04), YY1 (3.22E-05) |
hsa-miR-363 | E2F1 (4.16E-06), YY1 (5.45E-04) |
hsa-miR-375 | E2F1 (2.01E-05), SPI1 (2.85E-04), SP1 (1.33E-04), YY1 (5.30E-05) |
hsa-miR-449b | GATA (2.19E-03) |
hsa-miR-92a | E2F1 (8.13E-04), SPI1 (1.26E-03) |
hsa-miR-93 | E2F1 (1.11E-04), SP1 (7.39E-08), YY1(4.20E-05) |
When the target genes of one TF significantly overlap with several co-expressed target gene groups of a miRNA, only the smallest p-value of significant overlap for this TF is listed here.